BRS-X(Hormones-PM2) - Estrobolome Regulation
(Gut Bacteria That Recycle Oestrogen)
1. Mission & Overview
Mission
Shape systemic oestrogen exposure through microbiome-mediated regulation of oestrogen metabolism and recycling.
Overview
Supports microbiome-mediated regulation of oestrogen metabolism, deconjugation, recycling, and elimination through beta-glucuronidase activity and enterohepatic circulation (the estrobolome, the collective gut-microbial capacity to metabolise and recycle oestrogens). This pathway links gut ecology directly to systemic oestrogen exposure, meaning microbial composition can influence hormone levels independently of ovarian output itself. Fibre and plant-diversity intake that shapes microbial beta-glucuronidase activity therefore has downstream consequences for oestrogen signalling stability elsewhere in the system.
- Regulates oestrogen deconjugation and enterohepatic recycling via gut microbes.
- Links microbial composition to systemic oestrogen exposure.
- Shaped by fibre and plant-diversity intake influencing microbial enzymes.
2. Primary Biological Effects
↑ balanced oestrogen deconjugation/recycling context; ↓ dysbiotic beta-glucuronidase skew; ↑ enterohepatic regulation of sex-hormone exposure
3. Phenome Connections
These mappings are translational relationships, not single-mechanism outcome claims. Phenomes are emergent functional patterns supported by multiple interacting PMs across the BRAIN Framework. Biology → Phenome Confidence reflects how directly this mechanism's biology would be expected to affect the phenome within BRAIN architecture — not dietary treatment efficacy. Evidence Confidence (below Key References) reflects how convincing the attached evidence is for the Biology → Phenome relationship on that row.
These are three independent scores. They are not combined or averaged. A phenome can have Medium registry evidence while individual mechanism rows show different Biology → Phenome and Evidence scores.
1. Phenome Evidence Confidence (Phenome Registry only)
Question: How convincing is the foundational evidence that this phenome is a valid, well-defined functional construct — and that diet-relevant biology can plausibly connect to it?
Not a roll-up of Biology → Phenome Confidence or Evidence Confidence from Primary Mechanism page rows. Those are scored per mechanism; this score is assigned once per phenome at registry level.
Derived from foundational landmark evidence organised in up to three layers: construct validation, biology→phenome linkage, and nutrition→biology modulation. Each layer may include one or many landmark papers depending on registry review.
2. Biology → Phenome Confidence (Primary Mechanism page §3 rows)
Question: If this PM/FM biology were substantially impaired in isolation, how directly would that phenome be expected to suffer — within BRAIN architecture?
How it is derived: Reviewers read the PM/FM definition and biological function first — initially ignoring attached references and whether dietary intervention studies exist. References are reviewed only when scoring Evidence Confidence (below).
Score levels (the value shown on each row as Biology → Phenome Confidence):
- High — primary biological determinant (e.g. noradrenergic signalling → attention; GABA synthesis → calming tone)
- Medium — major contributory determinant, not the sole driver
- Low–Medium — established but indirect, modulatory, or one integrative step removed
- Low — distal, conditional, or weak biological coupling
“Not dietary treatment efficacy” means this score does not ask whether a diet or supplement treats the phenome. It asks whether the biology itself is architecturally relevant. Limited dietary RCT evidence belongs in Evidence Confidence, not here.
3. Evidence Confidence (Primary Mechanism page §3 rows)
Question: How convincing are the attached Key References on that specific row that this biology actually relates to this phenome?
How it is derived: Assigned after Biology → Phenome Confidence, by reviewing only the references on that PM/FM row. Judges whether refs support the relationship — not just mechanism or phenome in isolation.
- High — strong convergent human evidence directly linking mechanism biology to phenome variation
- Medium — multiple human lines supporting the relationship; may include one bridge study with an inferential step
- Low–Medium — convergent translational stack without direct mechanism↔phenome measurement on the row
- Low — mechanistic or preclinical only; mechanism and phenome supported separately but not bridged
Often equal to or lower than Biology → Phenome Confidence. Can occasionally be higher when outcome evidence is stronger than the mechanism's contributory role.
- Biology → Phenome Confidence: Low–Medium
- Rationale: The estrobolome can influence systemic oestrogen exposure through microbial beta-glucuronidase activity; downstream affective phenome effects are indirect and should not be presented as single-mechanism causal claims.
- Key References:
- Evidence Confidence: Low–Medium
- Biology → Phenome Confidence: Low–Medium
- Rationale: Altered oestrogen recycling may indirectly influence neural signalling context relevant to cognitive clarity without establishing direct single-pathway outcome certainty.
- Key References:
- Evidence Confidence: Low–Medium
- Biology → Phenome Confidence: Low–Medium
- Rationale: Estrobolome activity may support or disrupt oestrogen exposure depending on microbial beta-glucuronidase balance and enterohepatic recycling direction.
- Key References:
- Evidence Confidence: Low–Medium
4. Levers
Intervention Profile
Intervention Dominance: Diet-Dominant
- Fermentable fibre ← oats, legumes, vegetables, resistant starch sources
- Plant diversity ← varied whole-plant dietary patterns
- fermentable fibre
- plant diversity
-
Inulin/GOS ← onions, chicory, legumes
-
Pectin/soluble fibre ← oats, apples, flax seeds
-
Resistant starch ← cooled potatoes, cooled rice, green bananas
1. Food Preparation & Delivery ONLY
- Repeated daily fermentable substrate delivery matters more than isolated high-fibre meals.
- Soak overnight to reduce phytates and improve mineral bioavailability — see Oats — Preparation.
- Soak and cook thoroughly to reduce phytates and improve mineral bioavailability; soaking and spro… — see Lentils — Preparation.
- Prefer minimally refined whole-kernel or whole-flour products where tolerated. — see Whole Grains — Preparation.
- Prepare cruciferous vegetables to support myrosinase-dependent sulforaphane yield — see Broccoli Sprouts — Preparation.
- Antibiotic exposure and ultra-processed dietary displacement may work against estrobolome stability.
5. Mechanistic Basis
Summary
The estrobolome links microbial enzyme activity to systemic oestrogen exposure through enterohepatic circulation, constrained by fermentable substrate availability via BRS5(KC1) [Hu et al., 2023; Sui et al., 2021; Ervin et al., 2019].
(Microbial oestrogen metabolism)
Gut bacteria with beta-glucuronidase activity can deconjugate oestrogen metabolites in the intestinal lumen, influencing whether oestrogens are recycled via enterohepatic circulation or eliminated → [Hu et al., 2023]; [Sui et al., 2021]; [Ervin et al., 2019]
(Substrate dependence)
Fermentable fibre and diverse plant substrates support microbial ecology that may favour more balanced estrobolome function relative to low-fibre, ultra-processed dietary patterns.
(Boundaries of the mechanism)
Direct neural oestrogen signalling is owned by BRS-X(Hormones-PM1). Barrier containment and LPS context intersect via BRS5(FM1).
(Integration within BRS-X(Hormones))
This PM operationalises the gut-mediated oestrogen recycling arm of BRS-X(Hormones-FM1), dependent on BRS5(KC1) — Fermentable Fibre Availability.
5.1 Evidence Highlights
Introduction/Summary
Estrobolome and enterohepatic oestrogen recycling biology is well established. The studies below highlight microbial beta-glucuronidase activity and substrate dependence that refine how systemic oestrogen exposure is interpreted through the gut.
- Confidence: low-medium
- Evidence Level: mechanistic
- Rationale: Gut bacteria with beta-glucuronidase activity can deconjugate oestrogen metabolites in the intestinal lumen, influencing whether oestrogens are recycled via enterohepatic circulation or eliminated — central to microbiome-mediated oestrogen recycling and elimination [Hu et al., 2023]; [Sui et al., 2021]; [Ervin et al., 2019].
- Key References:
- Confidence: low-medium
- Evidence Level: mechanistic
- Rationale: Microbial beta-glucuronidase enzymes reactivate conjugated oestrogens as components of the estrobolome, modulating systemic oestrogen exposure independent of ovarian production alone [Ervin et al., 2019]; [Sui et al., 2021].
- Key References:
- Confidence: low-medium
- Evidence Level: mechanistic
- Rationale: Estrobolome function depends on fermentable fibre and diverse plant substrates supporting microbial ecology — constrained by BRS5(KC1) fermentable fibre availability rather than isolated oestrogen-modulating supplements [Hu et al., 2023].
- Key References:
6. BRS Pathways and Connections
6.1 BRS Pathways
- None listed
6.2 Cross-BRS Mechanism Relationships
Primary Mechanisms in other Biological Regulatory Systems that directly interact with, constrain or support this mechanism.
- BRS-X(Hormones-PM1) — Oestrogen Signalling Stability — bRS-X(Hormones-PM1) — Oestrogen Signalling Stability
- BRS1(FM1) — Monoaminergic Function — Gut-mediated oestrogen recycling
- BRS5-FM2-PM5 — SCFA Production & Signalling — sCFA Production & Signalling
- BRS5(FM1) — Gut Barrier Integrity & Immune Interface — gut Barrier Integrity & Immune Interface
- BRS6(FM1) — Glycaemic–Insulin Stability & Cognitive Energy Availability — Direct oestrogen neural signalling
6.3 Local BRS Mechanism Relationships
Related Primary Mechanisms within the same Biological Regulatory System that collectively support the integrated biological function.
- BRS-X(Hormones-PM1) — Oestrogen Signalling Stability
- BRS-X(Hormones-PM4) — Metabolic-Reproductive Hormone Integration
7. References
- Hu et al. (2023) — A Vital Regulator in Female Estrogen Metabolism
- Sui et al. (2021) — Role of Gut Microbial $\beta$-Glucuronidase in Estrogen Reactivation and Breast Cancer
- Ervin et al. (2019) — Gut Microbial $\beta$-glucuronidases Reactivate Estrogens As Components of the Estrobolome That Reactivate